Jiangbo Pharmaceuticals, Inc.(fka JGBO)

[Long-vestor]

that's about correct Acciptier however, colors also very, green red or black.. There's not much difference between them all in your description except the black. It's the strongest indicator and the most reliable.. they all Generally signify 3 candles up..,, It's created when the bears attempt to gain control and the bulls retrieve it. The black is a strong bull sign.. strong..

Fundamentally most of the generalization is is correct regarding price movement. The question has remained unanswered nearly a year.. "What's up with this China disallowing export of funds thange?searched the net some time ago and found nothing,, zip.. I believe others have done the same and the company has not made any formal nor indiscriminate answer. This is a cloud over the companies head.. YET Pope and their invetors show no sing of worry over this issue,, soo.. put that in your bank... they'd know far more then little ol'us..

Secondly as big asked some time ago, it's been understood by me that the answer to his question regarding the company diluting shares was that; it views, via Elsa, the shares as an equity, those which Pope and their partners hold in warrant by it are the asst not the mechanism.. I.E. when the stock rises to [for example]: double it's warrant valued price, the loan can be renegotiated and were it to be the same sum at half the amount of them. or simply,no different than your home loan as an asst. You don't 'hope' to give back your home and if it attains equity you can renegotiate values to receive funds or simply move to another broker pay it off, several variables open to the company's advantage.. double its value and only half are required to retain a new loan for the same sum.

regarding the recent dilution this first problem is too the second.. the transfer of funds was not a payment nor intentional dlution it was due to the inability of the company to transfer cash.. . it was a penalty and interest deposit.. stalling payments until cash can become transfered.

At least this is my personal observation of the problems..



other wise the company is sound Marjory profitable in one of the most toughest times for a pharmacy. a super plus..

Up-listing and promises of this is the first topic as well.. The NASDAQ nor any major exchange, as i understand, don't take shares as annual nor admittance payment,, If we can't transfer funds, then how we make annual and or quarterly payments to the exchange? how are we paying US staff, firms aiding admittance?


hammer that black candle and bingo, it predicts something regarding our current scenario is about to change.


Crocker? he's a crock. he's disruptive in Conference calls, cut off people who 'he' feels are waisting 'his' time. he rarely know squat about the company, and i have no clue why his so 'highly recommended.. IR, who's nothing but an answering machine.. hopefully they ain't paying him. lol. Fortunately, he changed his little IR story on his web site.. cause he's failed that promise for two years.

If yaw want to know 'something' call Elsa.. I haven't bothered her for many moons..


But that black hammer, it's dam rare they don't hammer in new highs.. 14.50 looks like a decent target.

I don't see no dilution, don't see no financial troubles, don't seen no lack of income nor lack of aggressiveness change in a fast growing concern.. dump the cash cloud and we're off to the races. a PR announcing the up listing and Elsa's conformation "it's filed" or that is, a simple PR saying this; is what me thinks is why that hammer popped up.. in the mean time once the cash cloud goes away,, we migrate to NASDAQ values.